Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,193 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

A Study of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin) in Participants With Solid Tumors

NCT03386942

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Eisai Trial Site 5 Matsuyama, Ehime, Japan
  • Eisai Trial Site 6 Kurume, Fukuoka, Japan
  • Eisai Trial Site 8 Sapporo, Hokkaido, Japan
  • Eisai Trial Site 4 Akashi, Hyōgo, Japan
View Trial Details
Completed

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

NCT02857270

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
View all 13 locations
View Trial Details
Completed

Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea

NCT03271554

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Inje University Busan Paik Hospital Busan, South Korea
  • Dong-A University Hospital Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
  • Kosin University Gospel Hospital Busan, South Korea
View all 37 locations
View Trial Details
Completed

An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC

NCT02409368

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution - 0002 Wels, Upper Austria, Austria
  • Local Institution - 0003 Salzburg, Austria
  • Local Institution - 0005 Vienna, Austria
  • Local Institution - 0173 Odense, Region Syddanmark, Denmark
View all 90 locations
View Trial Details
Completed

Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT)

NCT01982955

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital Beijing, China
  • Peking Union Medical College Hospital Beijing, China
  • Jilin Cancer Hospital Changchun, China
View all 44 locations
View Trial Details

Related conditions